189 related articles for article (PubMed ID: 29484909)
1. Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders.
Sagar-Ouriaghli I; Lievesley K; Santosh PJ
J Psychopharmacol; 2018 Jun; 32(6):641-653. PubMed ID: 29484909
[TBL] [Abstract][Full Text] [Related]
2. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
Zamzow RM; Ferguson BJ; Stichter JP; Porges EC; Ragsdale AS; Lewis ML; Beversdorf DQ
Psychopharmacology (Berl); 2016 Apr; 233(7):1171-8. PubMed ID: 26762378
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers.
Zamzow RM; Ferguson BJ; Ragsdale AS; Lewis ML; Beversdorf DQ
J Clin Exp Neuropsychol; 2017 Aug; 39(6):596-606. PubMed ID: 27841098
[TBL] [Abstract][Full Text] [Related]
4.
Hegarty JP; Zamzow RM; Ferguson BJ; Christ SE; Porges EC; Johnson JD; Beversdorf DQ
Autism; 2020 Apr; 24(3):795-801. PubMed ID: 31416333
[No Abstract] [Full Text] [Related]
5. Effect of propranolol on facial scanning in autism spectrum disorder: a preliminary investigation.
Zamzow RM; Christ SE; Saklayen SS; Moffitt AJ; Bodner KE; Higgins KF; Beversdorf DQ
J Clin Exp Neuropsychol; 2014; 36(4):431-45. PubMed ID: 24730708
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder.
Hegarty JP; Ferguson BJ; Zamzow RM; Rohowetz LJ; Johnson JD; Christ SE; Beversdorf DQ
Brain Imaging Behav; 2017 Oct; 11(5):1278-1289. PubMed ID: 27714553
[TBL] [Abstract][Full Text] [Related]
7. Key issues in Rett syndrome: emotional, behavioural and autonomic dysregulation (EBAD) - a target for clinical trials.
Singh J; Santosh P
Orphanet J Rare Dis; 2018 Jul; 13(1):128. PubMed ID: 30064458
[TBL] [Abstract][Full Text] [Related]
8. Neurogenic Fever in Severe Traumatic Brain Injury Treated with Propranolol: A Case Report.
Garg M; Garg K; Singh PK; Satyarthee GD; Agarwal D; Mahapatra AK; Sharma BS
Neurol India; 2019; 67(4):1097-1099. PubMed ID: 31512644
[TBL] [Abstract][Full Text] [Related]
9. Load matters: neural correlates of verbal working memory in children with autism spectrum disorder.
Vogan VM; Francis KE; Morgan BR; Smith ML; Taylor MJ
J Neurodev Disord; 2018 Jun; 10(1):19. PubMed ID: 29859034
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.
Parikh MS; Kolevzon A; Hollander E
J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):157-78. PubMed ID: 18439113
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder.
Beversdorf DQ; Ferguson B; Hunter S; Hirst K; Lolli B; Bellesheim KR; Barton AU; Muckerman J; Takahashi N; Selders K; Holem R; Sohl K; Dyke P; Stichter J; Mazurek M; Kanne S
Psychopharmacology (Berl); 2024 Jan; 241(1):19-32. PubMed ID: 38086927
[TBL] [Abstract][Full Text] [Related]
12. Exploring the neurocognitive correlates of challenging behaviours in young people with autism spectrum disorder.
Carter Leno V; Vitoratou S; Kent R; Charman T; Chandler S; Jones CR; Happé F; Baird G; Pickles A; Simonoff E
Autism; 2019 Jul; 23(5):1152-1164. PubMed ID: 30288984
[TBL] [Abstract][Full Text] [Related]
13. Challenging behaviours at early adulthood in autism spectrum disorders: topography, risk factors and evolution.
Rattaz C; Michelon C; Munir K; Baghdadli A
J Intellect Disabil Res; 2018 Jul; 62(7):637-649. PubMed ID: 29797498
[TBL] [Abstract][Full Text] [Related]
14. Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.
Narayanan A; White CA; Saklayen S; Scaduto MJ; Carpenter AL; Abduljalil A; Schmalbrock P; Beversdorf DQ
Brain Imaging Behav; 2010 Jun; 4(2):189-97. PubMed ID: 20502989
[TBL] [Abstract][Full Text] [Related]
15. Linking social motivation with social skill: The role of emotion dysregulation in autism spectrum disorder.
Neuhaus E; Webb SJ; Bernier RA
Dev Psychopathol; 2019 Aug; 31(3):931-943. PubMed ID: 30957732
[TBL] [Abstract][Full Text] [Related]
16. An update on pharmacotherapy of autism spectrum disorder in children and adolescents.
Goel R; Hong JS; Findling RL; Ji NY
Int Rev Psychiatry; 2018 Feb; 30(1):78-95. PubMed ID: 29693461
[TBL] [Abstract][Full Text] [Related]
17. Effect of propranolol on verbal problem solving in autism spectrum disorder.
Beversdorf DQ; Carpenter AL; Miller RF; Cios JS; Hillier A
Neurocase; 2008; 14(4):378-83. PubMed ID: 18766980
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Lamy M; Erickson CA
Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
[TBL] [Abstract][Full Text] [Related]
19. The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.
Beversdorf DQ
Semin Pediatr Neurol; 2020 Oct; 35():100834. PubMed ID: 32892961
[TBL] [Abstract][Full Text] [Related]
20. Emotion regulation in autism spectrum disorder: evidence from parent interviews and children's daily diaries.
Samson AC; Wells WM; Phillips JM; Hardan AY; Gross JJ
J Child Psychol Psychiatry; 2015 Aug; 56(8):903-13. PubMed ID: 25442191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
